Clinical Study Site — New York, New York

Clinical Study Site is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Clinical Study Site has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Chronic Inflammatory Demyelinating Polyneuropathy, Inflammatory Bowel Diseases, Colitis, Ulcerative.

Sponsors: Dianthus Therapeutics, Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company), Amicus Therapeutics.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Study Site?

Clinical Study Site has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Study Site conducted?

Clinical Study Site has 8 clinical trials on record, with 3 currently active. Their work covers Chronic Inflammatory Demyelinating Polyneuropathy, Inflammatory Bowel Diseases, Colitis, Ulcerative.

Is Clinical Study Site accredited by Crixeo Health?

Yes — Clinical Study Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Clinical Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.